Skip to main content

Table 4 Comparison of FEV1 between sensitised and non-sensitised patients with COPD 7.0–18.3% (weighted mean 13.6%

From: The global impact of Aspergillus infection on COPD

Author, year FEV1 % of predicted Number of patients
Sensitised Non-sensitised
Jin et al, 2014 [25] 37 41 142
Everaerts et al, 2017 [26] 41 43 300
Agarwal et al, 2010 [27] 52.9 48.9 200
Bafadhel, 2014 [28] 39 51 128
Weighted average (weighted SD) 43.0 (7.0) 45.5 (4.6)